[ITK-users] New Submission: Multimodal Analysis of Vasogenic Edema in Glioblastoma Patients for Radiotherapy Planning

[MIDAS Journal]

Hello,

A new submission has been added to the MIDAS Journal.

Title: Multimodal Analysis of Vasogenic Edema in Glioblastoma Patients for Radiotherapy Planning
Authors: Lê M., Delingette H., Kalpathy-Cramer J., Gerstner E., Shih H., Batchelor T., Unkelbach J., Ayache N.
Abstract: Glioblastoma (GBM) is the most common type of primary
brain tumor, which is characterized by an infiltrative growth pattern.
In current practice, radiotherapy planning is primarily based upon T2
FLAIR MRI despite its known lack of specificity in the detection of tu-
mor infiltration. While hyperintensity on T2 FLAIR is widely considered
to represent infiltrative tumor, it may also be caused by the presence
of vasogenic edema (VE), caused by a leakage of fluid into the brain
parenchyma. Distinguishing VE from infiltrative tumor could have im-
pact on improving radiotherapy planning. In this paper we study a data
set of 17 GBM patients treated with anti-angiogenic therapy for which
a fast decrease of T2 FLAIR hypersignal is observed, which indicates
the resolution of VE. We investigate if multimodal MRI acquisitions in-
cluding diffusion tensor imaging can distinguish between VE and tumor
infiltration prior to therapy. Using a random forest classifier, we show
that, in this study, morphological information based on the contrast en-
hanced T1 image explains up to 75% of the extent of VE. The information
from different imaging modalities did not significantly improve the clas-
sification. We then show that delineating the VE prior to therapy can
have substantial impact on radiotherapy target delineation, leading to
smaller treatment volumes and reducing potentially harmful radiation
dose to normal brain tissue.


Download and review this publication at: http://hdl.handle.net/10380/3500

Generated by the MIDAS Journal

You are receiving this email because you asked to be informed by the MIDAS Journal for new submissions. To change your email preference visit http://www.midasjournal.org/ .